Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew    SN.   GB0009223206

SMITH & NEPHEW (SN.)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
1309.5(c) 1316.5(c) 1340(c) 1341(c) 1352(c) Last
2 989 273 6 379 227 4 523 039 2 383 169 2 232 384 Volume
-0.95% +0.53% +1.79% +0.07% +0.82% Change
More quotes
Financials (USD)
Sales 2018 5 095 M
EBIT 2018 1 008 M
Net income 2018 662 M
Debt 2018 1 148 M
Yield 2018 1,84%
Sales 2019 5 294 M
EBIT 2019 1 121 M
Net income 2019 812 M
Debt 2019 801 M
Yield 2019 2,17%
P/E ratio 2018 23,70
P/E ratio 2019 20,15
EV / Sales2018 3,48x
EV / Sales2019 3,28x
Capitalization 16 563 M
More Financials
Company
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices.It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced... 
More about the company
Surperformance© ratings of Smith & Nephew
Trading Rating : Investor Rating :
More Ratings
Latest news on SMITH & NEPHEW
04/20SMITH & NEPHEW : U.S. Patents Awarded to Inventors in Utah (April 20)
AQ
04/20SMITH & NEPHEW : Study concludes that a burn wound management strategy including..
AQ
04/19SMITH & NEPHEW : Expert Connect Centre endorsed by Royal College of Surgeons
AQ
04/18SMITH & NEPHEW : Notice of Results
PU
04/18ZIMMER BIOMET : Hip and Knee Orthopedic Surgical Implants Market Analysis to 202..
AQ
04/13GLOBAL MI NEUROSURGERY DEVICES MARKE : Key Players profiled in this report are M..
AQ
04/12SMITH & NEPHEW : Proxy Statments
CO
04/08WPP WHIRLWIND : Sorrell may be out within weeks
AQ
04/07SMITH & NEPHEW : U.S. Patents Awarded to Inventors in Colorado (April 7)
AQ
04/07SMITH & NEPHEW : U.S. Patents Awarded to Inventors in Mississippi (April 7)
AQ
More news
Sector news : Medical Devices & Implants
04/19China May Request Minor Restrictions for Essilor Merger, Says Luxottica Chair..
DJ
04/19LUXOTTICA : chairman says China may seek 'minor restrictions' to clear Essilor d..
RE
04/04Smith & Nephew picks new CEO who sold his last company
RE
03/12Sensirion, Medartis to raise cash in Swiss IPO boom
RE
03/12STRAUMANN : Medartis to use IPO proceeds to expand amid rising implant demand
RE
More sector news : Medical Devices & Implants
4-Traders Strategies on SMITH & NEPHEW 
SMITH & NEPHEW  - 2015
Near a major level
SELL
SMITH & NEPHEW PLC - 2013
Lower limit of a trading channel
BUY
More Strategies
Latest Tweets
04/17CMO Today Newsletter: Roberto Quarta and WPP’s future, Netflix’s blockbuster .. 
04/16Roberto Quarta, who is leading ad giant WPP for an interim period following t..
9
04/16After the exit of long-term boss Martin Sorrell, selling a few businesses mig..
10
04/16$WPP (-4.5% pre) WWP Confirms CEO Sir Martin Sorrell to Step Down; Roberto Qu..
1
04/12$SN. Nephew plc New management at Smith Nephew could make the firm an acquis.. 
More tweets
Qtime:96
News from SeekingAlpha
04/04Smith & Nephew goes ex-dividend tomorrow 
04/03Smith & Nephew to name Nawana CEO 
02/21269 MARIJUANA STOCKS : Correction, Crash, Or Slow Descent? 
02/08Smith & Nephew's (SNN) CEO Olivier Bohuon on Q4 2017 Results - Earnings Call .. 
02/08Smith & Nephew plc reports FY results 
Chart SMITH & NEPHEW
Duration : Period :
Smith & Nephew Technical Analysis Chart | SN. | GB0009223206 | 4-Traders
Technical analysis trends SMITH & NEPHEW
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 19,5 $
Spread / Average Target 2,8%
EPS Revisions
Managers
NameTitle
Olivier Jean Bohuon Chief Executive Officer & Director
Roberto Quarta Chairman
Matthew R. Stober President-Global Operations
Graham Baker Chief Financial Officer & Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW4.97%16 563
STRYKER CORPORATION5.63%61 284
JAPAN LIFELINE CO., LTD.34.46%2 671
WRIGHT MEDICAL GROUP NV-11.67%2 043
GLAUKOS CORP15.98%1 034
OSSTEM IMPLANT CO LTD--.--%769